• Publications
  • Influence
Perspectives on cancer therapy‐induced mucosal injury
A frequent complication of anticancer treatment, oral and gastrointestinal (GI) mucositis, threatens the effectiveness of therapy because it leads to dose reductions, increases healthcare costs, andExpand
  • 1,111
  • 60
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.
PURPOSE Febrile neutropenia remains a potentially life-threatening complication of anticancer chemotherapy, but some patients are at low risk for serious medical complications. The purpose of thisExpand
  • 906
  • 60
Updated clinical practice guidelines for the prevention and treatment of mucositis
Considerable progress in research and clinical application has been made since the original guidelines for managing mucositis in cancer patients were published in 2004, and the first active drug forExpand
  • 750
  • 32
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of cancer therapy. The goal of this systematic review was to update the Multinational Association of Supportive Care in CancerExpand
  • 602
  • 26
  • PDF
Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis
Oral and gastrointestinal (GI) mucositis can affect up to 100% of patients undergoing high‐dose chemotherapy and hematopoietic stem cell transplantation, 80% of patients with malignancies of the headExpand
  • 709
  • 23
  • PDF
Adenovirus infections in adult recipients of blood and marrow transplants.
Adenoviruses are increasingly recognized pathogens that affect blood and marrow transplant (BMT) recipients. Experiences with 2889 adult BMT recipients were reviewed to study the incidence, clinicalExpand
  • 276
  • 17
  • PDF
Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
PURPOSE To study the risk, outcomes, and costs of radiation-induced oral mucositis (OM) among patients receiving radiotherapy (RT) to head and neck primary cancers. METHODS AND MATERIALS AExpand
  • 296
  • 16
Pseudomonas bacteremia. Retrospective analysis of 410 episodes.
We reviewed 410 episodes of Pseudomonas bacteremia occurring in patients with cancer during a ten-year period. Pseudomonas bacteremia was most common among patients with acute leukemia. The majorityExpand
  • 375
  • 15
Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.
The prognostic significance of major organ and tissue infection was examined in 909 episodes of bacteremia that were selected from 10 consecutive, randomized clinical trials of antibiotic therapy forExpand
  • 375
  • 15
  • PDF
Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.
Between 1972 and 1989, the incidence of viridans streptococcal bacteremia at the University of Texas M. D. Anderson Cancer Center in Houston increased from one case per 10,000 admissions to 47 casesExpand
  • 368
  • 14